UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland

Scandinavian journal of rheumatology, 2017-09, Vol.46 (5), p.359-363

2017

Volltextzugriff (PDF)

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

Rheumatology international, 2022-06, Vol.42 (6), p.1015-1025

2022

Volltextzugriff (PDF)

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

Arthritis research & therapy, 2010-01, Vol.12 (3), p.R122-R122

2010

Volltextzugriff (PDF)

FRI0194 Drug Survival on TNF Inhibitors in Patients with Rheumatoid Arthritis in Finland

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.500-500

2016

Volltextzugriff (PDF)

SAT0589 Medication Adherence in Rheumatoid Arthritis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs: A Register Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.882-883

2016

Volltextzugriff (PDF)

Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort

Scandinavian journal of rheumatology, 2017-11, Vol.46 (6), p.425-431

2017

Volltextzugriff (PDF)

SAT0090 Three out of Every Four Patients with Dmard-Naive Early Rheumatoid Arthritis Meet DAS28 Remission at 12 Months in Finland

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.697-698

2016

Volltextzugriff (PDF)

FRI0057 Two Thirds of Patients with Early Rheumatoid Arthritis (ERA) Meet DAS28 Remission at 3 Months-Results from the Finnish Early Rheumatoid Arthritis Study (FIN-ERA)

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.439-440

2015

Volltextzugriff (PDF)

Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis

Annals of the rheumatic diseases, 2003-09, Vol.62 (9), p.880-884

2003

Volltextzugriff (PDF)

FRI0428 Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.459-459

2013

Volltextzugriff (PDF)

Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis

Annals of the rheumatic diseases, 2000-07, Vol.59 (7), p.565-570

2000

Volltextzugriff (PDF)

Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial

Clinical and experimental rheumatology, 2016-11, Vol.34 (6), p.1038

2016

Volltextzugriff (PDF)

Ten-year follow up study of patients from a Yersinia pseudotuberculosis III outbreak

Clinical and experimental rheumatology, 1995-05, Vol.13 (3), p.333

1995

Volltextzugriff (PDF)

Effect of antimicrobial treatment on chronic reactive arthritis

Clinical and experimental rheumatology, 1993-05, Vol.11 (3), p.301

1993

Volltextzugriff (PDF)

Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial

Clinical and experimental rheumatology, 2010-01, Vol.28 (1), p.73

2010

Volltextzugriff (PDF)

Follow-up study of the effect of a three-month course of ciprofloxacin on the late prognosis of reactive arthritis

Arthritis research, 2001-01, Vol.3 (Suppl 2), p.P101-P101, Article P101

2001

Volltextzugriff (PDF)

Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one

Journal of rheumatology, 1997-10, Vol.24 (10), p.2047

1997

Volltextzugriff (PDF)

Automated Text Message–Enhanced Monitoring Versus Routine Monitoring in Early Rheumatoid Arthritis: A Randomized Trial

Arthritis care & research (2010), 2020-03, Vol.72 (3), p.319-325

2020

Volltextzugriff (PDF)

Early Targeted Combination Treatment With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs and Long‐Term Outcomes in Rheumatoid Arthritis: Ten‐Year Follow‐Up Results of a Randomized Clinical Trial

Arthritis care & research (2010), 2019-11, Vol.71 (11), p.1450-1458

2019

Volltextzugriff (PDF)

Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season

Clinical and experimental immunology, 2007-11, Vol.150 (2), p.274-278

2007

Volltextzugriff (PDF)

Biodistribution and radiation dosimetry of [11C]choline: a comparison between rat and human data

European journal of nuclear medicine and molecular imaging, 2010-05, Vol.37 (5), p.874-883

2010

Volltextzugriff (PDF)

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

The Lancet (British edition), 1999-05, Vol.353 (9164), p.1568-1573

1999

Volltextzugriff (PDF)

Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study

Seminars in arthritis and rheumatism, 2013-08, Vol.43 (1), p.55-62

2013

Volltextzugriff (PDF)

Outcomes of switching anti-TNF drugs in rheumatoid arthritis—a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN)

Clinical rheumatology, 2011-11, Vol.30 (11), p.1447-1454

2011

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(64)
Life Sciences & Biomedicine
(56)
Science & Technology
(56)
Female
(52)
Rheumatology
(50)
Male
(46)
Adult
(45)
Middle Aged
(42)
Biological And Medical Sciences
(29)
Medical Sciences
(28)
Adolescent
(20)
Diseases Of The Osteoarticular System
(20)
Rheumatoid Arthritis
(20)
Aged
(18)
Inflammatory Joint Diseases
(18)
Arthritis, Rheumatoid - Drug Therapy
(17)
Treatment Outcome
(15)
Antirheumatic Agents - Therapeutic Use
(13)
Drug Therapy, Combination
(12)
Reactive Arthritis
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

FRI0194 Drug Survival on TNF Inhibitors in Patients with Rheumatoid Arthritis in Finland

SAT0589 Medication Adherence in Rheumatoid Arthritis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs: A Register Study

Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort

SAT0090 Three out of Every Four Patients with Dmard-Naive Early Rheumatoid Arthritis Meet DAS28 Remission at 12 Months in Finland

FRI0057 Two Thirds of Patients with Early Rheumatoid Arthritis (ERA) Meet DAS28 Remission at 3 Months-Results from the Finnish Early Rheumatoid Arthritis Study (FIN-ERA)

Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis

FRI0428 Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study

Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial

Ten-year follow up study of patients from a Yersinia pseudotuberculosis III outbreak

Effect of antimicrobial treatment on chronic reactive arthritis

Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial

Follow-up study of the effect of a three-month course of ciprofloxacin on the late prognosis of reactive arthritis

Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one

Automated Text Message–Enhanced Monitoring Versus Routine Monitoring in Early Rheumatoid Arthritis: A Randomized Trial

Early Targeted Combination Treatment With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs and Long‐Term Outcomes in Rheumatoid Arthritis: Ten‐Year Follow‐Up Results of a Randomized Clinical Trial

Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season

Biodistribution and radiation dosimetry of [11C]choline: a comparison between rat and human data

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study

Outcomes of switching anti-TNF drugs in rheumatoid arthritis—a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN)

Suchergebnisse filtern